Skip to main content
Top
Published in: International Journal for Equity in Health 1/2020

Open Access 01-12-2020 | Research

Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China

Authors: Xiaofeng Jiang, Ping He, Dawei Zhu, Xuefeng Shi, Qingyue Meng

Published in: International Journal for Equity in Health | Issue 1/2020

Login to get access

Abstract

Background

As a key part of the new round of health reform, the zero-markup drug policy (ZMDP) removed the profit margins of drug sales at public health care facilities, and had some effects to the operation of these institutions. This study aims to assess whether the ZMDP has different impacts between county general and traditional Chinese medicine (TCM) hospitals.

Methods

We obtained longitudinal data from all county general and TCM hospitals of Shandong province in 2007–2017. We used difference-in-difference (DID) method to identify the overall and dynamic effects of the ZMDP.

Results

On average, after the implementation of the ZMDP, the share of revenue from medicine sales reduced by 16.47 and 10.42%, the revenue from medicine sales reduced by 24.04 and 11.58%, in county general and TCM hospitals, respectively. The gross revenue reduced by 5.07% in county general hospitals. The number of annual outpatient visits reduced by 11.22% in county TCM hospitals. Government subsidies increased by 199.22 and 89.3% in county general and TCM hospitals, respectively. The ZMDP reform was not significantly associated with the revenue and expenditure surplus, the number of annual outpatient visits and the number of annual inpatient visits in county general hospitals, the gross revenue, the revenue and expenditure surplus and the number of annual inpatient visits in county TCM hospitals. In terms of dynamic effects, the share of revenue from medicine sales, revenue from medicine sales, and gross revenue decreased by 20.20, 32.58 and 6.08% respectively, and up to 28.53, 63.89 and 17.94% after adoption, while government subsidies increased by around 170 to 200% in county general hospitals. The number of annual outpatient visits decreased by 9.70% and up to 18.84% in county TCM hospitals.

Conclusion

The ZMDP achieved its some initial goals of removing the profits from western medicines in county hospitals’ revenue without disrupting the normal operation, and had different impacts between county general and TCM hospitals. Meanwhile, some unintended consequences were also recognized through the analysis, such as the decline of the utilization of the TCM.
Literature
1.
go back to reference Parkin D. International comparisons of health expenditure. J Public Health Med. 1993;15:114–5.CrossRef Parkin D. International comparisons of health expenditure. J Public Health Med. 1993;15:114–5.CrossRef
2.
go back to reference Fan VY, Savedoff WD. The health financing transition: A conceptual framework and empirical evidence. Soc Sci Med. 2014;105:112–21. Fan VY, Savedoff WD. The health financing transition: A conceptual framework and empirical evidence. Soc Sci Med. 2014;105:112–21.
3.
go back to reference Fu H, Li L, Yip W. Intended and unintended impacts of price changes for drugs and medical services: evidence from China. Soc Sci Med. 2018;211:114–22.CrossRef Fu H, Li L, Yip W. Intended and unintended impacts of price changes for drugs and medical services: evidence from China. Soc Sci Med. 2018;211:114–22.CrossRef
4.
go back to reference Clemens J, Gottlieb JD. Do physicians’ financial incentives affect medical treatment and patient health? Am Econ Rev. 2014;104:1320–49.CrossRef Clemens J, Gottlieb JD. Do physicians’ financial incentives affect medical treatment and patient health? Am Econ Rev. 2014;104:1320–49.CrossRef
5.
go back to reference Iizuka T. Experts’ agency problems: evidence from the prescription drug market in Japan. RAND J Econ. 2008;38:844–62.CrossRef Iizuka T. Experts’ agency problems: evidence from the prescription drug market in Japan. RAND J Econ. 2008;38:844–62.CrossRef
6.
go back to reference Yip WC. Physician response to Medicare fee reductions: changes in the volume of coronary artery bypass graft (CABG) surgeries in the Medicare and private sectors. J Health Econ. 1998;17:675–99.CrossRef Yip WC. Physician response to Medicare fee reductions: changes in the volume of coronary artery bypass graft (CABG) surgeries in the Medicare and private sectors. J Health Econ. 1998;17:675–99.CrossRef
8.
go back to reference Shi X, Zhu D, Man X, Wang W, Zhu K, Nicholas S, et al. “The biggest reform to China’s health system”: did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals? Health Policy Plan. 2019;34(7):483–91. Shi X, Zhu D, Man X, Wang W, Zhu K, Nicholas S, et al. “The biggest reform to China’s health system”: did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals? Health Policy Plan. 2019;34(7):483–91.
9.
go back to reference Mahlich J, Kamae I, Sruamsiri R. Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment. Expert Rev Pharmacoecon Outcomes Res. 2018;18:339–48.CrossRef Mahlich J, Kamae I, Sruamsiri R. Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment. Expert Rev Pharmacoecon Outcomes Res. 2018;18:339–48.CrossRef
10.
go back to reference Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K. Pharmaceutical policy in China. Health Aff. 2008;27:1042–50.CrossRef Sun Q, Santoro MA, Meng Q, Liu C, Eggleston K. Pharmaceutical policy in China. Health Aff. 2008;27:1042–50.CrossRef
11.
go back to reference Meng Q, Yang H, Chen W, Sun Q, Liu X. People’s republic of China health system review. Health Syst Transit. 2015;5:2–3. Meng Q, Yang H, Chen W, Sun Q, Liu X. People’s republic of China health system review. Health Syst Transit. 2015;5:2–3.
13.
go back to reference Zhu D, Shi X, Nicholas S, Bai Q, He P. Impact of China’s healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study. BMJ Open. 2019;9:e029646.CrossRef Zhu D, Shi X, Nicholas S, Bai Q, He P. Impact of China’s healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study. BMJ Open. 2019;9:e029646.CrossRef
14.
go back to reference Wang L, Suo S, Li J, Hu Y, Li P, Wang Y, et al. An investigation into traditional Chinese medicine hospitals in China: development trend and medical service innovation. Int J Health Policy Manag. 2016;6:19–25.CrossRef Wang L, Suo S, Li J, Hu Y, Li P, Wang Y, et al. An investigation into traditional Chinese medicine hospitals in China: development trend and medical service innovation. Int J Health Policy Manag. 2016;6:19–25.CrossRef
15.
go back to reference Sommers E, Porter K. Price Elasticities for three types of CAM Services: experiences of a Boston public health clinic. J Altern Complement Med. 2006;12:85–90.CrossRef Sommers E, Porter K. Price Elasticities for three types of CAM Services: experiences of a Boston public health clinic. J Altern Complement Med. 2006;12:85–90.CrossRef
16.
go back to reference Yi H, Miller G, Zhang L, Li S, Rozelle S. Intended and unintended consequences of China’s zero markup drug policy. Health Aff. 2015;34:1391–8.CrossRef Yi H, Miller G, Zhang L, Li S, Rozelle S. Intended and unintended consequences of China’s zero markup drug policy. Health Aff. 2015;34:1391–8.CrossRef
17.
go back to reference Fu H, Li L, Li M, Yang C, Hsiao W. An evaluation of systemic reforms of public hospitals: the Sanming model in China. Health Policy Plan. 2017;32:1135–45.CrossRef Fu H, Li L, Li M, Yang C, Hsiao W. An evaluation of systemic reforms of public hospitals: the Sanming model in China. Health Policy Plan. 2017;32:1135–45.CrossRef
18.
go back to reference Zhou Z, Su Y, Campbell B, Zhou Z, Gao J, Yu Q, et al. The Financial Impact of the ‘Zero-Markup Policy for Essential Drugs’ on Patients in County Hospitals in Western Rural China. PLoS One. 2015;10:e0121630 Zhang H, editor.CrossRef Zhou Z, Su Y, Campbell B, Zhou Z, Gao J, Yu Q, et al. The Financial Impact of the ‘Zero-Markup Policy for Essential Drugs’ on Patients in County Hospitals in Western Rural China. PLoS One. 2015;10:e0121630 Zhang H, editor.CrossRef
19.
go back to reference Zhang X, Wu Q, Liu G, Li Y, Gao L, Guo B, et al. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health Centres: evidence from a longitudinal study. BMJ Open. 2014;4:e006471.CrossRef Zhang X, Wu Q, Liu G, Li Y, Gao L, Guo B, et al. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health Centres: evidence from a longitudinal study. BMJ Open. 2014;4:e006471.CrossRef
20.
go back to reference National Health and Family Planning Commission. China Health and family planning Yearbook. Beijing: China Union Medical University Press; 2017. National Health and Family Planning Commission. China Health and family planning Yearbook. Beijing: China Union Medical University Press; 2017.
22.
go back to reference Jin L. From mainstream to marginal? Trends in the use of Chinese medicine in China from 1991 to 2004. Soc Sci Med. 2010;71:1063–7.CrossRef Jin L. From mainstream to marginal? Trends in the use of Chinese medicine in China from 1991 to 2004. Soc Sci Med. 2010;71:1063–7.CrossRef
Metadata
Title
Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China
Authors
Xiaofeng Jiang
Ping He
Dawei Zhu
Xuefeng Shi
Qingyue Meng
Publication date
01-12-2020
Publisher
BioMed Central
Published in
International Journal for Equity in Health / Issue 1/2020
Electronic ISSN: 1475-9276
DOI
https://doi.org/10.1186/s12939-020-01326-w

Other articles of this Issue 1/2020

International Journal for Equity in Health 1/2020 Go to the issue